B. Eckert
B. Eckert publishes mostly in Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Hematology, on topics such as Multiple Sclerosis Research Studies, Birth, Development, and Health and Sphingolipid Metabolism and Signaling.
- World rank
- #5,545,875 of 7,710,434 ranked researchers
- Rank in Switzerland
- #69,878 of 80,918
- Works
- 22
- Citations
- 170
- Citations per work
- 7.7
What does B. Eckert research?
B. Eckert's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (4%), Economics, Econometrics and Finance (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1150.1%
- Health Sciences940.9%
- Medicine940.9%
- Life Sciences14.5%
- Social Sciences14.5%
- 1Pathology and Forensic Medicine20% of their works
- 2Pediatrics, Perinatology and Child Health9% of their works
- 3Hematology7% of their works
- 4Economics and Econometrics4% of their works
- 5Neurology4% of their works
- 6Molecular Biology4% of their works
Research topics
- Multiple Sclerosis Research Studies
- Birth, Development, and Health
- Sphingolipid Metabolism and Signaling
- Immunodeficiency and Autoimmune Disorders
- Chronic Lymphocytic Leukemia Research
- Health Systems, Economic Evaluations, Quality of Life
- Cancer Genomics and Diagnostics
- Statistical Methods in Clinical Trials
Which keywords describe B. Eckert's research?
The keywords of their largest research topics: Diagnostic Criteria, Multiple Sclerosis, Early-Life Conditions, Fetal Programming, Chronic Lymphocytic Leukemia, Cost-effectiveness Analysis, Genetic Mutations and Genomic Aberrations.
- Mutational Signatures
- Cancer Genomics
- Sphingosine-1-Phosphate
- Quality of Life
- Genomic Aberrations
- Cost-effectiveness Analysis
- Fetal Programming
- Multiple Sclerosis
- Diagnostic Criteria
- Early-Life Conditions
- Chronic Lymphocytic Leukemia
- Genetic Mutations
- Primary Immunodeficiency
- Sphingolipids
- Adaptive Designs
- False Discovery Rate
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Diagnostic Criteria81 topic
- Multiple Sclerosis81 topic
- Early-Life Conditions31 topic
- Fetal Programming31 topic
- Chronic Lymphocytic Leukemia21 topic
- Cost-effectiveness Analysis21 topic
- Genetic Mutations21 topic
- Genomic Aberrations21 topic
- Primary Immunodeficiency21 topic
- Quality of Life21 topic
- Sphingolipids21 topic
- Sphingosine-1-Phosphate21 topic
- Adaptive Designs11 topic
- Cancer Genomics11 topic
- False Discovery Rate11 topic
- Mutational Signatures11 topic
Where does B. Eckert work?
B. Eckert's main affiliation in the publication record is Novartis (Switzerland), Switzerland.
How many publications and citations does B. Eckert have?
OpenAlex counts 22 works and 170 citations for B. Eckert, an h-index of 5, ranking #5,545,875 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named B. Eckert
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about B. Eckert. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.